News Stada expands OTC business with portfolio of GSK drugs Richard Staines allergy, dermatology, GlaxoSmithKline, M&A, OTC, Stada 0 Comment Germany’s Stada is to expand its over-the-counter business after agreeing to buy a portfolio of consumer health products Share X Stada expands OTC business with portfolio of GSK drugs https://pharmaphorum.com/news/stada-expands-otc-business-with-portfolio-of-gsk-drugs/
News/ News/ Sales and Marketing Takeda nets $660m from product selloff to Germany’s Stada Phil Taylor emerging markets, generic, OTC, Russia, Stada, Takeda 0 Comment Takeda has divested another block of products it views as lying outside its main focus, selling various drugs Share X Takeda nets $660m from product selloff to Germany’s Stada https://pharmaphorum.com/news/takeda-nets-660m-from-product-selloff-to-germanys-stada/
allergy, dermatology, GlaxoSmithKline, M&A, OTC, Stada
0 Comment
